The Antibodies Market was worth $ 95.217 Billion in 2016 and estimated to reach $ 161.897 Billion by the end of 2021 with a growing potential of 11.20 %.
Browse market data tables and in-depth TOC of the Global Antibodies Market to 2021 at www.marketdataforecast.com/market-…dies-market-1177/
Antibodies are proteins that are produced in response to specific antigens by plasma cells. They are also called as immunoglobulin.
These antibodies are used as diagnostics as well as Therapeutic purposes for several indications of diseases, including but not limited to, rheumatoid arthritis, non-Hodgkin lymphoma, psoriasis, Crohn’s disease, macular degeneration, hypercholesterolemia, and asthma. Owing to a number of product launches, antibodies market is projected to witness steady growth.
Effective harmonisation of product development, approval and registration guidelines in some of the major markets, such as United States and European Union can speed up the research and development of antibody related products.
Major factors that are primarily driving the Global antibodies market are continuous development of innovative products, increased adoption rate to therapeutic antibodies in cost-sensitive markets, rise in chronic illnesses owing to population shift and increasing longevity, swift approval by regulatory authorities for breakthrough therapies, and adoption of diagnostic antibodies. Companies are adopting to various strategies, like expansion of products indications to sustain the dynamically growing market.
High cost of treatment and side effects associated with antibodies treatment can hamper the growth of global antibodies market.
Based on product type, the market is segmented into Monoclonal Antibodies, Polyclonal Antibodies, and Anti-body drug complexes. The monoclonal antibodies are further segmented into Murine, Chimeric, Humanized, and Human.
The polyclonal antibodies are further categorized into Type I, Type II, Type III, Type IV, Type V, Type VI, Type VII, Type VIII. The Antibody-Drug Complexes are further segmented into Immunogen Technology, Seattle Genetics Technology, and Immunomedics Technology.
Monoclonal antibodies segment accounts for the highest market share in the market.
Based on Indication, the market is segmented into Cancer, Auto immune diseases, Infectious diseases, cardiovascular diseases, and CNS disorders, others (Inflammatory, Microbial Diseases, & Other). Based on end users, the market is segmented into Hospitals/Clinics, Research institute, Diagnostics laboratories.
Cancer indication type segment is predicted to account highest market share over the forecast period due to broad range applications of monoclonal antibodies for the treatment of various cancers.
Based on Application, the market is segmented into Medical, Experimental. The Experimental segment is further categorized into Western blot, ELISA, Radioimmune Assays, immunofluorescence, others (Immunohistochemistry, Immunoprecipitation, & Immunocytochemistry).
Hospitals is predicted to account the highest share in global antibodies market during the forecast period.
Global Antibodies Market Geographical Analysis
- North America
- Latin America
- Middle East & Africa
Global Antibodies Market Leaders' Analysis
- Abbott Diagnostics (U.S.)
- Novartis AG (Switzerland)
- Pfizer Inc. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Eli Lilly and Company (U.S.)
- A.G. Scientific, Inc. (U.S.)
- Bristol-Myers Squibb (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- AbbVie Inc. (U.S.)
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: